Cocaine Related Disorders Completed Phase 2 / 3 Trials for Caffeine (DB00201)

IndicationStatusPhase
DBCOND0037604 (Cocaine Related Disorders)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00495092Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent PatientsTreatment